Cargando…
JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC
Autores principales: | Li, Shu-Man, He, Li-Ru, Chen, Jie-Wei, Zhou, Jie, Nie, Run-Cong, Jin, Xiao-Han, Wang, Xin, Fu, Jian-Hua, Wang, Feng-Wei, Xie, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447641/ https://www.ncbi.nlm.nih.gov/pubmed/32843613 http://dx.doi.org/10.1038/s41392-020-00282-9 |
Ejemplares similares
-
Histone demethylase JMJD2C: epigenetic regulators in tumors
por: Zhang, Chengcheng, et al.
Publicado: (2017) -
JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Liu, Honggang, et al.
Publicado: (2023) -
Recent Findings in the Posttranslational Modifications of PD-L1
por: Li, Shu-Man, et al.
Publicado: (2020) -
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
por: Aprelikova, Olga, et al.
Publicado: (2016) -
Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response
por: Wang, Kai, et al.
Publicado: (2022)